LGND Enterprise Value
$2.13 B
-$40.44 M-1.86%
Wed, 22 Jan 2025 21:51:21 GMT
Summary:
As of January 23, 2025, LGND enterprise value is $2.13 billion, with a fall of -$40.44 million (-1.86%) during the most recent trading day. Over the past year, it has increased by +$861.31 million (+67.73%). LGND enterprise value is now -67.14% below its all-time high of $6.49 billion.LGND Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -1.9% | -1.8% | -1.8% |
| 1 m1 month | +1.1% | +1.1% | +1.1% |
| 3 m3 months | - | +9.6% | +8.8% |
| 6 m6 months | - | +19.2% | +14.2% |
| ytdytd | +8.5% | +8.3% | +8.3% |
| 1 y1 year | +67.7% | +69.9% | +57.9% |
| 5 y5 years | +0.9% | +42.7% | +27.0% |
LGND Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $2.17 B | -1.9% | $1.83 B | +16.3% |
| 3 m | 3-month | $2.32 B | -7.9% | $1.83 B | +16.3% |
| 6 m | 6-month | $2.32 B | -7.9% | $1.77 B | +20.6% |
| 1 y | 1-year | $2.32 B | -7.9% | $1.17 B | +81.6% |
| 3 y | 3-year | $2.40 B | -11.2% | $851 M | +150.8% |
| 5 y | 5-year | $3.88 B | -45.0% | $851 M | +150.8% |
| alltime | all time | $6.49 B | -67.1% | $102 M | +1981.7% |
Ligand Pharmaceuticals Incorporated Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $2.13 B(+8.5%) |
| 2024 | $1.97 B(+58.7%) |
| 2023 | $1.24 B(+5.4%) |
| 2022 | $1.18 B(-59.4%) |
| 2021 | $2.89 B(+44.2%) |
| 2020 | $2.01 B(-13.9%) |
| 2019 | $2.33 B(-30.1%) |
| 2018 | $3.34 B(+7.7%) |
| 2017 | $3.10 B(+33.7%) |
| 2016 | $2.32 B(+2.3%) |
| 2015 | $2.27 B(+110.5%) |
| 2014 | $1.08 B(+0.3%) |
| 2013 | $1.07 B(+134.9%) |
| 2012 | $457.22 M(+79.0%) |
| 2011 | $255.47 M(+49.7%) |
| Date | Value |
|---|---|
| 2010 | $170.67 M(-37.6%) |
| 2009 | $273.40 M(-3.4%) |
| 2008 | $282.92 M(-25.7%) |
| 2007 | $380.72 M(-60.9%) |
| 2006 | $972.98 M(+5.7%) |
| 2005 | $920.81 M(-1.1%) |
| 2004 | $931.09 M(-21.7%) |
| 2003 | $1.19 B(+138.4%) |
| 2002 | $498.59 M(-58.3%) |
| 2001 | $1.20 B(+30.0%) |
| 2000 | $920.46 M(+16.0%) |
| 1999 | $793.50 M(+34.0%) |
| 1998 | $592.03 M(+21.4%) |
| 1997 | $487.63 M(-1.5%) |
| 1996 | $494.81 M(+115.8%) |
| 1995 | $229.30 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated enterprise value?
- What is the all time high enterprise value for Ligand Pharmaceuticals Incorporated?
- What is LGND enterprise value year-to-date change?
- What is Ligand Pharmaceuticals Incorporated enterprise value year-on-year change?
What is Ligand Pharmaceuticals Incorporated enterprise value?
The current enterprise value of LGND is $2.13 B
What is the all time high enterprise value for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high enterprise value is $6.49 B
What is LGND enterprise value year-to-date change?
Ligand Pharmaceuticals Incorporated enterprise value has changed by +$167.22 M (+8.51%) since the beginning of the year
What is Ligand Pharmaceuticals Incorporated enterprise value year-on-year change?
Over the past year, LGND enterprise value has changed by +$861.31 M (+67.73%)